# Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia

> **NCT01251627** · PHASE2 · COMPLETED · sponsor: **Fondazione Italiana Sindromi Mielodisplastiche-ETS** · enrollment: 43 (actual)

## Conditions studied

- Chronic Myelomonocytic Leukemia

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT01251627
- **Lead sponsor:** Fondazione Italiana Sindromi Mielodisplastiche-ETS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-12
- **Final completion:** 2018-06
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01251627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01251627, "Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01251627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*